title: The inhibition of neuronal calcium ion channels by trace levels of yttrium released from carbon nanotubes.
abstract: Carbon nanotubes (CNTs) are used with increasing frequency in neuroengineering applications. CNT scaffolds are used to transmit electrical stimulation to cultured neurons and to control outgrowth and branching patterns of neurites. CNTs have been reported to disrupt normal neuronal function including alterations in endocytotic capability and inhibition of ion channels. Calcium ion channels regulate numerous neuronal and cellular functions including endo and exocytosis, neurite outgrowth, and gene expression. Strong CNT interactions with neuronal calcium ion channels would have profound biological implications. Here we show that physiological solutions containing CNTs inhibit neuronal voltage-gated calcium ion channels in a dose-dependent and CNT sample-dependent manner with IC50 as low as 1.2 microg/ml. Importantly, we demonstrate that the inhibitory activity does not involve tubular graphene as previously reported, but rather very low concentrations of soluble yttrium released from the nanotube growth catalyst. Cationic yttrium potently inhibits calcium ion channel function with an inhibitory efficacy, IC50, of 0.07 ppm w/w. Because of this potency, unpurified and even some reportedly "purified" CNT samples contain sufficient bioavailable yttrium to inhibit channel function. Our results have important implications for emerging nano-neurotechnology and highlight the critical role that trace components can play in the biological response to complex nanomaterials.
authors.affiliation: Division of Engineering, Brown University, Providence, RI 02912, USA.
authors.forename: Lorin M
authors.initials: LM
authors.lastname: Jakubek
authors.forename: Spiro
authors.initials: S
authors.lastname: Marangoudakis
authors.forename: Jesica
authors.initials: J
authors.lastname: Raingo
authors.forename: Xinyuan
authors.initials: X
authors.lastname: Liu
authors.forename: Diane
authors.initials: D
authors.lastname: Lipscombe
authors.forename: Robert H
authors.initials: RH
authors.lastname: Hurt
mesh_terms: D015220:Calcium Channels / Q000187:drug effects*; D002460:Cell Line; D006801:Humans; D046529:Microscopy, Electron, Transmission; D037742:Nanotubes, Carbon / Q000737:chemistry* / Q000648:ultrastructure; D009532:Nickel / Q000009:adverse effects; D015019:Yttrium / Q000494:pharmacology*
chemical_list: D015220:Calcium Channels; D037742:Nanotubes, Carbon; D015019:Yttrium; D009532:Nickel
references.citation: J Gen Physiol. 1984 Jun;83(6):941-67
references.pmid: 6330284
references.citation: J Physiol. 1993 Sep;469:639-52
references.pmid: 8271221
references.citation: Annu Rev Physiol. 2003;65:133-59
references.pmid: 12471162
references.citation: J Neurosci. 2007 Jun 27;27(26):6931-6
references.pmid: 17596441
references.citation: Neuron. 1997 Jan;18(1):153-66
references.pmid: 9010213
references.citation: Small. 2008 Jun;4(6):721-7
references.pmid: 18504717
references.citation: Nanotechnology. 2008 May 7;19(18):185706
references.pmid: 21825702
references.citation: J Mol Neurosci. 2000 Jun;14(3):175-82
references.pmid: 10984193
references.citation: Environ Health Perspect. 2005 Jul;113(7):823-39
references.pmid: 16002369
references.citation: Nat Nanotechnol. 2008 Jul;3(7):434-9
references.pmid: 18654569
references.citation: Neuron. 2008 Sep 25;59(6):882-901
references.pmid: 18817729
references.citation: Nature. 2006 Jul 13;442(7099):164-71
references.pmid: 16838014
references.citation: Nat Nanotechnol. 2009 Feb;4(2):126-33
references.pmid: 19197316
references.citation: Nanomedicine (Lond). 2008 Apr;3(2):183-99
references.pmid: 18373425
references.citation: Nanotechnology. 2008 Jan 9;19(1):015101
references.pmid: 21730521
references.citation: J Biol Chem. 2003 Dec 12;278(50):50212-6
references.pmid: 14522977
references.citation: Carbon N Y. 2008 Mar;46(3):489-500
references.pmid: 19255622
references.citation: Nano Lett. 2006 Jun;6(6):1261-8
references.pmid: 16771591
references.citation: Nano Lett. 2004 Mar;4(3):507-511
references.pmid: 21394241
references.citation: Nat Neurosci. 2007 Mar;10(3):285-92
references.pmid: 17293861
references.citation: Nano Lett. 2005 Jun;5(6):1107-10
references.pmid: 15943451
references.citation: J Membr Biol. 2002 Jun 1;187(3):225-38
references.pmid: 12163980
references.citation: J Nanosci Nanotechnol. 2005 Oct;5(10):1707-12
references.pmid: 16245532
references.citation: Nat Rev Drug Discov. 2008 Apr;7(4):358-68
references.pmid: 18356919
references.citation: Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5675-9
references.pmid: 15060274
references.citation: Toxicol Lett. 2007 Jan 10;168(1):58-74
references.pmid: 17141434
references.citation: J Neurophysiol. 2004 Nov;92(5):2820-30
references.pmid: 15201306
references.citation: Toxicol Lett. 2006 Aug 1;165(1):88-100
references.pmid: 16527436
references.citation: Nano Lett. 2008 Oct;8(10):3538-42
references.pmid: 18759491